EA201390003A1 - Пероральная терапия дефицита железа - Google Patents
Пероральная терапия дефицита железаInfo
- Publication number
- EA201390003A1 EA201390003A1 EA201390003A EA201390003A EA201390003A1 EA 201390003 A1 EA201390003 A1 EA 201390003A1 EA 201390003 A EA201390003 A EA 201390003A EA 201390003 A EA201390003 A EA 201390003A EA 201390003 A1 EA201390003 A1 EA 201390003A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- iron deficiency
- oral treatment
- iron
- deficiency
- normalize
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Способы нормализации уровней железа, лечения дефицита железа и связанных с этим расстройств, таких как анемия, согласно описанию. Описаны также фармацевтические композиции, эффективные для таких видов лечения.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35314610P | 2010-06-09 | 2010-06-09 | |
PCT/US2011/039737 WO2011156563A2 (en) | 2010-06-09 | 2011-06-09 | Oral iron deficiency therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201390003A1 true EA201390003A1 (ru) | 2013-06-28 |
EA026713B1 EA026713B1 (ru) | 2017-05-31 |
Family
ID=45098662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201390003A EA026713B1 (ru) | 2010-06-09 | 2011-06-09 | Твердая пероральная лекарственная форма для лечения дефицита железа или анемии и ее применение |
Country Status (9)
Country | Link |
---|---|
US (1) | US9402864B2 (ru) |
EP (1) | EP2579868B1 (ru) |
JP (1) | JP5865903B2 (ru) |
KR (1) | KR101811376B1 (ru) |
CN (1) | CN103025327A (ru) |
AU (1) | AU2011264808B2 (ru) |
CA (1) | CA2802184C (ru) |
EA (1) | EA026713B1 (ru) |
WO (1) | WO2011156563A2 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20121350A1 (it) * | 2012-07-31 | 2014-02-01 | Alesco Srl | Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro. |
ES2657601T3 (es) | 2012-08-23 | 2018-03-06 | Emisphere Technologies, Inc. | Compuestos de fenoxi alquil dietanolamina y diisopropanolamina para la administración de agentes activos |
KR102084489B1 (ko) * | 2018-05-18 | 2020-03-04 | 강원대학교산학협력단 | 열용융압출법을 이용하여 제조된 철 나노콜로이드 분산체 및 이의 용도 |
AU2019100771B4 (en) * | 2018-07-17 | 2019-09-26 | Ferromedica Pty Ltd | Ferrous Sulphate Formulations and Uses Thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2212396A (en) | 1987-12-18 | 1989-07-26 | Procter & Gamble | Dietary supplement comprising calcium and delayed release coated iron |
ATE288415T1 (de) * | 1999-04-05 | 2005-02-15 | Emisphere Tech Inc | Dinatrium-salze, monohydrate und ethanol-solvate |
US7049283B2 (en) * | 2000-12-06 | 2006-05-23 | Novartis Ag | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
EP1542704A1 (en) * | 2002-04-18 | 2005-06-22 | Stephen H. Embury | Method and composition for preventing pain in sickle cell patients |
WO2004104018A2 (en) | 2003-05-14 | 2004-12-02 | Emisphere Technologies, Inc. | Compositions for delivering peptide yy and pyy agonists |
JP4702745B2 (ja) | 2003-07-18 | 2011-06-15 | 株式会社林原生物化学研究所 | ミネラル吸収促進剤及びその用途 |
KR20060109922A (ko) * | 2003-10-31 | 2006-10-23 | 알자 코포레이션 | 가바펜틴 및 프리가발린의 개선된 흡수를 위한 조성물 및제형 |
WO2006076692A1 (en) * | 2005-01-12 | 2006-07-20 | Emisphere Technologies, Inc. | Compositions for buccal delivery of parathyroid hormone |
WO2006118948A2 (en) * | 2005-04-29 | 2006-11-09 | Cubist Pharmaceuticals, Inc. | Therapeutic compositions |
US7585527B2 (en) * | 2005-09-19 | 2009-09-08 | Bala Venkataraman | Composition and method for treating iron deficiency anemia |
CA2819234A1 (en) | 2011-01-07 | 2012-07-12 | Merrion Research Iii Limited | Pharmaceutical compositions of iron for oral administration |
WO2012097155A1 (en) * | 2011-01-14 | 2012-07-19 | Chiasma Inc. | Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof |
-
2011
- 2011-06-09 JP JP2013514358A patent/JP5865903B2/ja not_active Expired - Fee Related
- 2011-06-09 US US13/703,283 patent/US9402864B2/en active Active
- 2011-06-09 EA EA201390003A patent/EA026713B1/ru not_active IP Right Cessation
- 2011-06-09 CN CN2011800361593A patent/CN103025327A/zh active Pending
- 2011-06-09 EP EP11793140.2A patent/EP2579868B1/en not_active Not-in-force
- 2011-06-09 AU AU2011264808A patent/AU2011264808B2/en not_active Ceased
- 2011-06-09 CA CA2802184A patent/CA2802184C/en not_active Expired - Fee Related
- 2011-06-09 KR KR1020137000637A patent/KR101811376B1/ko active IP Right Grant
- 2011-06-09 WO PCT/US2011/039737 patent/WO2011156563A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011156563A2 (en) | 2011-12-15 |
JP2013528224A (ja) | 2013-07-08 |
US20130230604A1 (en) | 2013-09-05 |
AU2011264808B2 (en) | 2015-01-22 |
CA2802184A1 (en) | 2011-12-15 |
JP5865903B2 (ja) | 2016-02-17 |
CA2802184C (en) | 2019-01-08 |
EP2579868A4 (en) | 2014-08-06 |
CN103025327A (zh) | 2013-04-03 |
KR101811376B1 (ko) | 2017-12-22 |
EP2579868B1 (en) | 2018-03-07 |
KR20130112859A (ko) | 2013-10-14 |
AU2011264808A1 (en) | 2013-01-24 |
EP2579868A2 (en) | 2013-04-17 |
WO2011156563A3 (en) | 2012-02-02 |
EA026713B1 (ru) | 2017-05-31 |
US9402864B2 (en) | 2016-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201691461A1 (ru) | Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения | |
EA201391615A1 (ru) | Дейтерированные потенциаторы cftr | |
EA201590987A1 (ru) | Соединения и способы их применения | |
EA201101686A1 (ru) | Новые композиции для лечения шмт и связанных с ней расстройств | |
UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
EA201491412A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201100138A1 (ru) | 4-феноксиметилпиперидины в качестве модуляторов активности gpr119 | |
EA201300471A1 (ru) | Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3 | |
UA115983C2 (uk) | Інгібітори днк-пк | |
EA201590165A1 (ru) | Сдерживающие злоупотребление фармацевтические композиции для контролируемого высвобождения | |
EA201491766A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
EA201290919A1 (ru) | Индазольные соединения и их применение | |
EA201170349A1 (ru) | Модуляторы mif | |
EA201291356A1 (ru) | Пиперидиноновые производные как ингибиторы mdm2 для лечения рака | |
EA201200473A1 (ru) | Замещенные (гетероарилметил)тиогидантоины | |
EA201290836A1 (ru) | Связанные бис-арильные арилтриазолоны и их применение | |
EA201390803A1 (ru) | Ингибиторы бромодомена и их применение | |
EA201201665A1 (ru) | Новые соединения | |
IN2013CN01340A (ru) | ||
EA201100750A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
EA201290322A1 (ru) | Лечение желудочно-кишечных расстройств | |
EA201200570A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
EA201171435A1 (ru) | Твердые фармацевтические композиции и способы их получения | |
EA201101479A1 (ru) | Новые p2x7r антагонисты и их применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |